Review Reports
- Patricia Guevara-Ramírez †,
- Elius Paz-Cruz † and
- Ana Karina Zambrano *
- et al.
Reviewer 1: Anonymous Reviewer 2: Anonymous Reviewer 3: Anonymous
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsThe review by Gueavara-Ramirez covers an imporant issue of relationshipt between immunology, endocrinology and gastrointestinal microbiota in patients with atopic dermatitis.
This work seems to present comprehensive summary of current stage of knowledge but some minor improvements are still needed.
Comments:
- Contents of the abstract present a veriaty of information from different domaing and mix different mechanisms of action at biochemical, endocrynological and immue levels. I suggest to arrange the contents of the abstract in more coherent way and focus on the main findings of the review, leaving mechanistic details for the discussion.
- Although this is a narrative review, the presented evidence should be comprehensively summarized. Such factors as the study type, population and type of evaluation remain crucial for the interpretation of its results. This was done properly for the relationship between microbiota and hormones, but the paragraph 3 should be supported with similar summary too.
- There are multiple references with some mistakes such as inappropriate authors, journals, issues or pages. All the references are ultimately identifiable, however, proper formatting is obligatory here.
Author Response
The review by Guevara-Ramirez covers an important issue of relationship between immunology, endocrinology and gastrointestinal microbiota in patients with atopic dermatitis.
This work seems to present comprehensive summary of current stage of knowledge but some minor improvements are still needed.
We sincerely thank the reviewer for the thoughtful comments and constructive suggestions. All corresponding changes in the revised manuscript are highlighted in yellow. Our point-by-point responses are provided below.
Comments:
- Contents of the abstract present a veriaty of information from different domaing and mix different mechanisms of action at biochemical, endocrynological and immue levels. I suggest to arrange the contents of the abstract in more coherent way and focus on the main findings of the review, leaving mechanistic details for the discussion.
Response: We thank the reviewer for this valuable suggestion. The Abstract was completely reorganized to improve coherence and readability following the journal guidelines. It now presents the background, scope of the review, principal findings, and conclusions in a logical sequence, while mechanistic details were moved to the main text. We also moderated statements implying causality and emphasized that the proposed hormone–microbiota–immune interactions represent a hypothesis-generating framework supported mainly by indirect evidence.
2. Although this is a narrative review, the presented evidence should be comprehensively summarized. Such factors as the study type, population and type of evaluation remain crucial for the interpretation of its results. This was done properly for the relationship between microbiota and hormones, but the paragraph 3 should be supported with similar summary too.
Response: We thank the reviewer for this important recommendation. To better summarize the evidence presented in Section 3, we added Table 1, which provides an overview of the available evidence according to study type, study population or experimental model, principal outcomes evaluated, overall evidence, and key references for progesterone and testosterone in AD. This summary complements the narrative text and facilitates interpretation of the available evidence.
3. There are multiple references with some mistakes such as inappropriate authors, journals, issues or pages. All the references are ultimately identifiable, however, proper formatting is obligatory here.
Response: We thank the reviewer for pointing this out. The reference list was carefully reviewed and corrected to ensure consistency in author names, journal titles, publication details, page numbers, DOI formatting, and overall compliance with the journal style.
Author Response File:
Author Response.pdf
Reviewer 2 Report
Comments and Suggestions for AuthorsThis article is an engaging overview of an important topic. I have only very minor suggestions and comments regarding typography.
Line 13: Specify the sex-related effect to clarify Line 32.
Line 267: Italicize "in vitro".
Line 272: Italicize "Helicobacter pylori".
Line 436: Italicize "Staphylococcus aureus".
Line 441: Italicize "S. aureus".
Line 446: Italicize "Staphylococcus aureus".
Line 509: Italicize "in vitro".
Fig. 1: Box labeled "HOW DYSBIOSIS INFLUENCES HORMONES"—instead of "Alters microbial...", specify the type of alteration.
Fig. 1: Box labeled "EFFECT ON SERUM HORMONE LEVELS"—state the specific effects rather than simply mentioning alterations or dysregulation.
Author Response
This article is an engaging overview of an important topic. I have only very minor suggestions and comments regarding typography.
We sincerely thank the reviewer for the positive evaluation of our manuscript and for the helpful suggestions. All corresponding changes in the revised manuscript are highlighted in yellow. Our point-by-point responses are provided below.
Line 13: Specify the sex-related effect to clarify Line 32.
Line 267: Italicize "in vitro".
Line 272: Italicize "Helicobacter pylori".
Line 436: Italicize "Staphylococcus aureus".
Line 441: Italicize "S. aureus".
Line 446: Italicize "Staphylococcus aureus".
Line 509: Italicize "in vitro".
Fig. 1: Box labeled "HOW DYSBIOSIS INFLUENCES HORMONES"—instead of "Alters microbial...", specify the type of alteration.
Fig. 1: Box labeled "EFFECT ON SERUM HORMONE LEVELS"—state the specific effects rather than simply mentioning alterations or dysregulation.
Response: We thank the reviewer for these helpful comments. The Abstract was revised to specify the sex-related effects of progesterone and testosterone more clearly. In addition, all scientific names and the term in vitro were italicized throughout the manuscript. Figure 1 was also revised by replacing the generic statements with more specific descriptions. The box "HOW DYSBIOSIS INFLUENCES HORMONES" now states "Increases microbial β-glucuronidase activity, promoting steroid hormone reactivation", while the box "EFFECT ON SERUM HORMONE LEVELS" now specifies "Altered steroid hormone bioavailability, disrupted endocrine homeostasis, and altered estrogen–androgen balance.
Author Response File:
Author Response.pdf
Reviewer 3 Report
Comments and Suggestions for AuthorsThe manuscript attempts to present a narrative review of the originally "independent" three threads of sex hormones, intestinal microecology, and AD immune barrier around "progesterone, testosterone, intestinal flora and the immune-epithelial interaction of atopic dermatitis (AD)". The topic selection closely follows the cutting-edge but still immature field of the "hormone-microbiota-skin axis". The overall framework is clear and the evidence integration has a certain degree of systematicness. Based on the mechanism review, Tables 1-4 and the discussion section, the following review comments are given:
- The essence of the mechanism integration in this review is a hypothesis sorting based on "biological rationality" rather than a definite pathway conclusion, which can help subsequent researchers clarify the "core link that needs to be prioritized for verification" : Is the fluctuation of progesterone in the luteal phase of AD patients accompanied by a decrease in SCFAs producing bacteria?
- Table 1 (progesterone - Microbiota) and Table 2 (Testosterone - Microbiota) suggest adding a column titled "Direct/Indirect Association Strength between Evidence and AD" (for example: "Direct AD Population", "Pregnancy Model", "In vitro Sterol Metabolism"), to facilitate readers' quick determination of whether a change in a certain microbiota can be extrapolated to the AD context
- In the "Early Life Programming" section of Table 4, a sentence can be added: "Maternal progesterone fluctuations, delivery methods, and feeding jointly shape the infant microbiota. This window is most likely to become the entry point for combined hormone-microbiota intervention in the Future", corresponding to "Future Perspectives"
- References can be added after "maintenance of epithelial integrity" on line 392:3390/foods11193108;References need to be added in the application of intestinal microecological inflammation and metabolic adjustment:10.1016/j.ijbiomac.2023.128588
- Regarding whether the 3β-HSD activity of bacteria such as Ruminococcus truly affects the circulating progesterone/testosterone levels, the current human evidence is extremely limited. It is recommended to clarify: Such microbial transformation is more likely to act on the local sterol pool in the intestinal lumen. Its systemic endocrine effect needs to be comprehensively judged in combination with intestinal permeability and the efficiency of enterohepatic circulation, and should not be directly equated with "peripheral hormone clearance".
Author Response
The manuscript attempts to present a narrative review of the originally "independent" three threads of sex hormones, intestinal microecology, and AD immune barrier around "progesterone, testosterone, intestinal flora and the immune-epithelial interaction of atopic dermatitis (AD)". The topic selection closely follows the cutting-edge but still immature field of the "hormone-microbiota-skin axis". The overall framework is clear and the evidence integration has a certain degree of systematicness.
We sincerely thank the reviewer for the constructive comments and insightful suggestions. All corresponding changes in the revised manuscript are highlighted in yellow. Our point-by-point responses are provided below.
Based on the mechanism review, Tables 1-4 and the discussion section, the following review comments are given:
1. The essence of the mechanism integration in this review is a hypothesis sorting based on "biological rationality" rather than a definite pathway conclusion, which can help subsequent researchers clarify the "core link that needs to be prioritized for verification" : Is the fluctuation of progesterone in the luteal phase of AD patients accompanied by a decrease in SCFAs producing bacteria?
Response: We thank the reviewer for this insightful observation. We agree that the endocrine–microbial–immune interactions integrated in this review should be interpreted as a hypothesis-generating framework grounded in biological plausibility and supported predominantly by indirect evidence, rather than as a confirmed causal pathway in patients with atopic dermatitis.
Accordingly, we revised the Abstract, Study Selection Criteria, Discussion, limitations, Table 4, Figure 1 legend, Future Perspectives, and Conclusions to consistently clarify the evidentiary status of the proposed model. We also moderated statements that could have implied established causality and explicitly distinguished biologically plausible mechanisms from relationships that still require direct validation.
In addition, we incorporated the reviewer’s proposed question as a priority for future research. Specifically, we now highlight the need for longitudinal studies to determine whether luteal-phase increases in progesterone among women with atopic dermatitis are temporally associated with reduced abundance or metabolic activity of SCFA-producing taxa, lower SCFA concentrations, impaired epithelial barrier function, and greater disease activity. We further indicate that such studies should integrate repeated hormonal, microbial, metabolomic, barrier-related, and clinical measurements while accounting for relevant confounding factors.
2. Table 1 (progesterone - Microbiota) and Table 2 (Testosterone - Microbiota) suggest adding a column titled "Direct/Indirect Association Strength between Evidence and AD" (for example: "Direct AD Population", "Pregnancy Model", "In vitro Sterol Metabolism"), to facilitate readers' quick determination of whether a change in a certain microbiota can be extrapolated to the AD context
Response: We thank the reviewer for this valuable suggestion. We added a new column entitled "Applicability to the AD context" to Tables 1 and 2. This column classifies the relevance of each study to AD as "Indirect but mechanistically relevant" or "Limited applicability", together with a brief justification explaining how each finding may (or may not) be extrapolated to AD pathophysiology. We also added a footnote clarifying that this classification reflects the applicability of the evidence to AD rather than its methodological quality or risk of bias.
3. In the "Early Life Programming" section of Table 4, a sentence can be added: "Maternal progesterone fluctuations, delivery methods, and feeding jointly shape the infant microbiota. This window is most likely to become the entry point for combined hormone-microbiota intervention in the Future", corresponding to "Future Perspectives"
Response: We thank the reviewer for this valuable suggestion. We revised the “Early-life microbial programming and allergy susceptibility” section of Table 4 to indicate that maternal progesterone dynamics, mode of delivery, and feeding practices may jointly influence infant microbial colonization. We also clarified that the perinatal and early postnatal period may represent a promising developmental window for future preventive strategies integrating hormonal, nutritional, and microbiota-related factors.
To ensure consistency with the reviewer’s recommendation, we expanded the corresponding paragraph in the Future Perspectives section. The revised text highlights the need for prospective mother–infant birth cohorts that jointly evaluate maternal hormonal conditions, mode of delivery, antibiotic exposure, breastfeeding, formula feeding, complementary feeding, and infant microbiota composition. We used cautious language because combined hormone–microbiota interventions have not yet been clinically validated in the context of AD.
4. References can be added after "maintenance of epithelial integrity" on line 392:3390/foods11193108;References need to be added in the application of intestinal microecological inflammation and metabolic adjustment:10.1016/j.ijbiomac.2023.128588
Response: We thank the reviewer for these reference recommendations. We carefully evaluated both suggested articles and considered their relevance to the corresponding statements in the manuscript.
Regarding the article with DOI 10.3390/foods11193108, we found that it primarily evaluates the bioavailability and transepithelial transport of red wine phenolic compounds using an in vitro digestion/Caco-2 cell model. In this study, transepithelial electrical resistance was used to confirm the integrity of the Caco-2 monolayer before the transport experiments. However, the article does not directly evaluate the microbial taxa discussed in our manuscript or their contribution to intestinal epithelial barrier maintenance.
Consequently, we considered that adding this reference immediately after the statement concerning Faecalibacterium, Roseburia, Ruminococcus, Bifidobacterium, and members of the Lachnospiraceae family could imply a direct evidentiary relationship that was not examined in the suggested study. To maintain consistency between the statement and its supporting evidence, we therefore did not include this citation at that location.
In contrast, the article with DOI 10.1016/j.ijbiomac.2023.128588 was considered relevant to the discussion of microbiota-directed metabolic modulation. We incorporated this reference into the Future Perspectives section, where emerging microbiota-targeted approaches are discussed. Specifically, we added a statement indicating that preclinical evidence suggests that bioactive polysaccharides can modulate gut microbial composition and contribute to the regulation of glycolipid metabolism. Because this study was conducted in an experimental model and did not specifically evaluate atopic dermatitis, we also clarified that the relevance of these microbiota-mediated metabolic effects to inflammatory pathways and clinical outcomes in AD remains to be established.
5. Regarding whether the 3β-HSD activity of bacteria such as Ruminococcus truly affects the circulating progesterone/testosterone levels, the current human evidence is extremely limited. It is recommended to clarify: Such microbial transformation is more likely to act on the local sterol pool in the intestinal lumen. Its systemic endocrine effect needs to be comprehensively judged in combination with intestinal permeability and the efficiency of enterohepatic circulation, and should not be directly equated with "peripheral hormone clearance".
Response: We thank the reviewer for this important clarification. We agree that bacterial steroid-transforming activity, including hydroxysteroid dehydrogenase and steroid reductase activity, should not be directly interpreted as evidence of peripheral progesterone or testosterone clearance in humans.
Accordingly, we revised the Abstract, Section 4, Section 4.1, the relevant entries in Tables 1 and 2, and the Discussion. The revised manuscript now emphasizes that microbial steroid transformation primarily affects the local intestinal sterol pool. We also clarify that any systemic endocrine effect would depend on additional physiological factors, including luminal substrate availability, intestinal permeability, metabolite absorption, hepatic first-pass metabolism, conjugation and deconjugation reactions, and the efficiency of enterohepatic circulation.
Furthermore, we now explicitly state that the presence or activity of bacterial steroid-transforming enzymes does not demonstrate clinically meaningful changes in circulating progesterone or testosterone concentrations in humans. The potential contribution of these local microbial transformations to mucosal immunity, epithelial barrier function, systemic inflammation, or AD severity is therefore presented as a biologically plausible and testable hypothesis rather than as an established mechanism.
Author Response File:
Author Response.pdf